BioLight Life Sciences (XTAE:BOLT) Accounts Payable & Accrued Expense : ₪0.13 Mil (As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is BioLight Life Sciences Accounts Payable & Accrued Expense?

BioLight Life Sciences's quarterly accounts payable & accrued expense increased from Dec. 2023 (₪0.24 Mil) to Jun. 2024 (₪2.68 Mil) but then declined from Jun. 2024 (₪2.68 Mil) to Dec. 2024 (₪0.13 Mil).

BioLight Life Sciences's annual accounts payable & accrued expense declined from Dec. 2022 (₪0.30 Mil) to Dec. 2023 (₪0.24 Mil) and declined from Dec. 2023 (₪0.24 Mil) to Dec. 2024 (₪0.13 Mil).

BioLight Life Sciences Accounts Payable & Accrued Expense Historical Data

The historical data trend for BioLight Life Sciences's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLight Life Sciences Accounts Payable & Accrued Expense Chart

BioLight Life Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.58

0.15

0.30

0.24

0.13

BioLight Life Sciences Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.30	-	0.24	2.68	0.13

BioLight Life Sciences Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

BioLight Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLight Life Sciences Ltd (XTAE:BOLT) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Aba Hillel Silver 12, 11 floor, Ramat Gan, ISR, 5250606

Website

http://www.bio-light.co.il

BioLight Life Sciences Ltd is an emerging ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.